NOVEL NANOMATERIALS FOR HEPATOBILIARY DISEASES TREATMENT AND FUTURE PERSPECTIVES

Hepatobiliary diseases are serious universal health concerns that affects the liver and is responsible for around 2 million deaths annually. The limitations of standard drug-delivery systems, such as unequal and nonspecific drug distribution, which result in adverse effects on healthy tissues and a reduction in drug bioavailability, make successful therapy difficult even when choices for surgery and medicine are available. With the liver's distinct physiological and anatomical features, nanotechnology offers a potential approach to targeted medication delivery, making it a prime target for nanomedicine. In the context of liver illnesses, a number of nanomaterial categories, such as polymer, inorganic and…